Estrategias Combinadas en Inmunoterapia Traslacional
ITC
University of Paris-Sorbonne
París, FranciaPublicaciones en colaboración con investigadores/as de University of Paris-Sorbonne (9)
2024
2023
-
Sequencing of Ipilimumab Plus Nivolumab and Encorafenib Plus Binimetinib for Untreated BRAF -Mutated Metastatic Melanoma (SECOMBIT): A Randomized, Three-Arm, Open-Label Phase II Trial
Journal of Clinical Oncology, Vol. 41, Núm. 2, pp. 212-221
2020
-
Diacylglycerol kinase ζ promotes actin cytoskeleton remodeling and mechanical forces at the B cell immune synapse
Science Signaling, Vol. 13, Núm. 627
-
Growth/Differentiation Factor-15 (GDF-15): From Biomarker to Novel Targetable Immune Checkpoint
Frontiers in Immunology, Vol. 11
-
Immunological impact of cell death signaling driven by radiation on the tumor microenvironment
Nature Immunology, Vol. 21, Núm. 2, pp. 120-134
2017
-
Predictors of responses to immune checkpoint blockade in advanced melanoma
Nature Communications, Vol. 8, Núm. 1
2016
-
Immunodynamics: A cancer immunotherapy trials network review of immune monitoring in immuno-oncology clinical trials
Journal for ImmunoTherapy of Cancer, Vol. 4, Núm. 1
2015
-
Future perspectives in melanoma research: Meeting report from the "Melanoma Bridge": Napoli, December 3rd-6th 2014
Journal of Translational Medicine, Vol. 13, Núm. 1
2014
-
Classification of current anticancer immunotherapies
Oncotarget, Vol. 5, Núm. 24, pp. 12472-12508